Expert Opinion on Practice Patterns in Mild Asthma After the GINA 2019 Updates: A Major Shift in Treatment Paradigms from a Long-Standing SABA-Only Approach to a Risk Reduction-Based Strategy with the Use of Symptom-Driven (As-Needed) Low-Dose ICS/LABA.
Curr Allergy Asthma Rep. 2022 Oct;22(10):123-134. doi: 10.1007/s11882-022-01038-x. Epub 2022 Jun 11.
Curr Allergy Asthma Rep. 2022.
PMID: 35689764
Review.